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type-2 diabetes mellitus has not been satisfactory as it is not 
successful in treating associated cardiovascular risk factors, 
which is the main cause of morbidity.[4] The current trend is 
therefore, to make therapy better by choosing appropriate 
combination of available drugs. A parallel search for newer 
drugs is also being made.
Thiazolidine-2,4-diones are the class of oral hypoglycemic 
agents which increase insulin sensitivity at target tissues 
such as liver and skeletal muscles. In addition, it also 
improves the markers of cardiovascular risk factors by 
decreasing the free fatty acids and altering the lipoprotein 
metabolism.[5] Thiazolidine-2,4-diones act on peroxisome 
proliferators activating receptor-γ (PPAR-γ) receptors 
which regulate the gene expression mainly in the adipose 
tissues.[6-8] Rosiglitazone and pioglitazone molecules from 
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ABSTRACT
The compounds, 2-(methylsulfonyl)-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylic acid (DM3), 
2-(phenylsulfonyl)-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylic acid (DM4), and 2-(p-toluenesulfonyl)-
1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylic acid (DM5) were synthesized by coupling of 
1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylic acid (DM2) with methanesulfonyl chloride, benzenesulfonyl 
chloride, and toluenesulfonyl chloride, which in turn, was synthesized by dissolving dilute aqueous ammonia 
with 2-(N-hydroxy methyl amino)-indol-3-yl-propanoic acid (DM1) which is the reaction product of l-tryptophan 
and formalin. All the intermediates and title compounds were characterized by physical, chemical, analytical, 
and spectral data. All the title compounds have been screened for in vivo antidiabetic activity in streptozotocin-
induced diabetic rats, and serum glucose was estimated spectrophotometrically at 505 nm by glucose oxidase/
peroxidase method. Compound DM5 showed potent antidiabetic activity.
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the class of thioglitazone available in the market are 
showing severe adverse effects.[9,10]
A survey of literature revealed that replacement of the 
thiazolidine-2,4-dione ring by various acidic groups such 
as α-heteroatom-substituted carboxylic acids and α-carbon-
substituted carboxylic acids can results in qualitative and 
quantitative changes in the activity,[11-13] which prompted 
us to undertake the synthesis of various new derivatives 
with the aim of having improved activity and less toxicity.
MATERIALS AND METHODS
The melting points were recorded in open sulphuric acid 
or oil bath using thermometer and were uncorrected. 
IR spectra were recorded using Hitachi 270-30 infrared 
and Bruker Vector 22 spectrophotometers using KBr 
pellet techniques. 1H-NMR spectrum was recorded using 
DMSO-d6 on Bruker Avance DPX-200 at 300 MHz, and 
their chemical shifts are recorded in δ (parts per million) 
units with respect to tetramethyl silane (TMS) as an internal 
standard. Atmospheric pressure ionization (API) mass 
spectra were recorded on Bruker Ion Trap Esquire 3000 
spectrometer with the ionization potential 3000 V. Progress 
of the reactions was monitored using TLC, performed on 
aluminum plates precoated with silica gel-G, using chloroform–
methanol (92:8) as the solvent systems, and the spots were 
visualized by exposure to iodine vapors. The physical constants 
of the title compounds are reported in Table 1.
Procedure for the preparation of 2-(N-hydroxymethyl 
amino)-indol-3-yl-propanoic acid (DM1)
In a 250-mL conical flask, 5 g (0.0245 M) of l-tryptophan 
was dissolved in 120 mL of water. To this, 20 mL formalin 
was added and the mixture was incubated at 38°C for 6 
h. The colorless, crystalline, but rather granular solid that 
had then separated was collected, washed with cold water, 
and dried in vacuum. The crude product was recrystallized 
from hot water.
IR (KBr) (cm–1): 3600–3400 (m) broad O–H stretching, 
3300 (m) N–H stretching, 3099 (m) aromatic C–H 
stretching (asymmetric), 3056 (m) aromatic C–H 
stretching (symmetric), 2989 (m) aliphatic C–H stretching 
(asymmetric), 2852 (m) aliphatic C–H stretching 
(symmetric), 1680 (s) carbonyl stretching 1620, 1552, 1447 
(m) skeleton in plane vibrations C=C, 1408–1425 (s) C=C 
and C=N ring stretching, 750 (m) N–H wagging, 741 (s) 
out of plane C=C bending.
1H-NMR (DMSO-d6, 300 MHz), δ (ppm): 7.36–7.45 (m, 
4H, ArH), 7.10 (s, 1H, α proton of indole ring), 3.70–3.80 
(s, 1H, aromatic N–H, D2O exchangeable), 2.80 {d, 2H, 
–CH2 (Jvic = 7.2)}, 3.88 {t, 1H, –CH (Jvic = 7.2)}, 11.00 (s, 
1H, COOH), 2.10 (s, 1H, NH, D2O exchangeable), 4.60 
(s, 2H, –CH2), 4.10 (s, 1H, OH). 
Mass spectra: Molecular ion peak M at m/e 234 (23.8%), 
[M–(OH)]+ and [M–(H2O)]+ shows peak at m/e 217 
(32.4%), 216 (100%). The other important ions are at m/e 
190 (10.5%), 158 (8.4%), 157 (11.8%), 156 (15.3), 144 
(10.8%), 117 (18.6%), and 91 (8.5%).
Procedure for the preparation of 1,2,3,4-tetrahydro-
9H-pyrido [3,4-b] indole-3-carboxylic acid (DM2): In a 
250-mL conical flask, 150 mL of dilute aqueous ammonia 
was placed and 5 g (0.0214 M) of α-hydroxymethylamino-
β-3-indolylpropionic acid (DM1) was added and dissolved. 
Then, this solution was refluxed for 3 h and concentrated 
to a small volume. The white-to-cream colored crystals 
obtained were given charcoal treatment and filtered by 
suction, washed with cold water and dried at 80°C. The 
product was obtained in colorless leaflets and was purified 
by recrystallization from hot water.
IR (KBr) (cm–1): 3650–3300 (m) broad O–H stretching, 
3350 (m) N–H stretching, 3100 (m) aromatic C–H 
stretching (asymmetric), 3056 (m) aromatic C–H 
stretching (symmetric), 2990 (m) aliphatic C–H stretching 
(asymmetric), 2850 (m) aliphatic C–H stretching 
(symmetric), 1690 (s) carbonyl stretching 1600, 1582, 1450 
(m) skeleton in plane vibrations C=C, 1410–1430(s) C=C 
and C=N ring stretching, 760 (m) N–H wagging, 752 (s) 
out of plane C=C bending.
Table 1: Physical constants of intermediates and title compounds
Compound code Molecular formula Molecular weight Yield,  
%
Melting point  
(°C)
Solvent system 
chloroform:methanol
Rf values
DM1 C12H12N2O3 234.32 75 230–231 92:8 0.50
DM2 C12H12N2O2 216.23 80 312–313 92:8 0.72
DM3 C12H14N2O4S 294.32 70 240–242 92:8 0.62
DM4 C18H16N2O4S 356.39 78 262–263 92:8 0.69
DM5 C19H18N2O4S 370.42 74 274–275 92:8 0.67
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1H-NMR (DMSO-d6, 300 MHz), δ (ppm): 7.10–7.56 
(m, 4H, ArH), 3.70–3.80 (s, 1H, aromatic N–H, D2O 
exchangeable), 2.80 {d, 2H, –CH2 (Jvic = 7.2)}, 3.88 
{t, 1H, CH (Jvic = 7.2)}, 11.00 (s, 1H, COOH), 2.10   
(s, 1H, NH of piperidine ring, D2O exchangeable), 4.10 
(s, 2H, CH2).
Mass spectra: Molecular ion peak M at m/e 216 (100%), 
[M–(OH)]+ and [M–(C2H2)]+ shows peak at m/e 199 
(18.4%), 190 (27.2%). The other important ions are at 
m/e 177 (19.7%), 144 (14.3%), 118 (5.8%), 117 (20.5%), 
91 (6.2%), 91 (5.8%).
Procedure for the preparation of 2-(methylsulfonyl)-
1,2,3,4-tetrahydro-9H-pyrido [3,4-b]indole-3-
carboxylic acid (DM3)
Treated 3 g (0.01389 M) of the amine (DM2) with 50 
mL of 10% sodium hydroxide solution and 2 mL (3.5 g, 
0.0303 M) of methanesulfonyl chloride was added in small 
proportions. The reaction mixture was stirred vigorously 
for 30 min and warmed it slightly with continued shaking. 
When the odor of methanesulfonyl chloride was dissipated, 
the mixture was cooled in an ice bath. As oil separated, 
crystallization was induced by rubbing the inner wall of the 
beaker with the glass rod in an ice bath. Any solid produced 
should be separated by filtration; and the crude product 
was recrystallized from dilute ethanol to give pure DM3 as 
light brown crystals.
IR (KBr) (cm–1): 3600–3400 (Broad O–H stretching), 
3300 (N–H stretching), 3099 (aromatic C–H stretching 
asymmetric), 3056 (aromatic C–H stretching symmetric), 
2989 (aliphatic C–H stretching asymmetric), 2852 
(aliphatic C–H stretching symmetric), 1680 (carbonyl 
stretching), 1620, 1552, 1447 (skeleton in plane vibrations 
C=C), 748 (N–H wagging), 741 (s) out of plane C=C 
bending, 1330 (s) SO2 stretching asymmetric, 1120 (s) 
SO2 stretching symmetric, 560 (s) SO2 rocking, 530 (s) 
SO2 scissoring.
1H-NMR (DMSO-d6, 300 MHz), δ (ppm): 7.10–7.40 
(m, 4H, ArH), 3.70–3.80 (s, 1H, aromatic N–H, D2O 
exchangeable), 2.80 {d, 2H, –CH2 (Jvic = 7.2)}, 3.88 {t, 
1H, –CH (Jvic = 7.2)}, 11.00 (s, 1H, COOH), 2.90 (s, 3H, 
–SO2CH3), 3.80–3.85 (m, 2H, –CH2).
Mass spectra: Molecular ion peak M at m/e 294 (43.9%), 
[M–(OH)]+ shows peak at m/e 277 (26.2%). The other 
important ions are at m/e 249 (10.8%), 216 (100%), 144 
(12.2%), 118 (6.4%), 117 (20.5%), 107 (6.2%), 91 (16.5%), 
79 (8.4%).
Procedure for the preparation of 2-(phenylsulfonyl)-
1,2,3,4-tetrahydro-9H-pyrido [3,4-b] indole-3-
carboxylic acid (DM4)
To a 100-mL round bottom flask was added 3 g (0.01389 
M) of amine (DM2), 20 mL of dry pyridine, and 2 mL 
(2.75 g, 0.01559 M) of benzene sulfonylchloride. The 
reaction mixture was refluxed for 2 h on heating mantle 
and poured into crushed ice to give a light-brownish solid. 
As oil separated, crystallization was induced by rubbing the 
inner wall of the beaker with the glass rod in an ice bath. 
Any solid produced should be separated by filtration, and 
the crude product was recrystallized from dilute ethanol 
to give pure DM4 as light brown crystals.
IR (KBr) (cm–1): 3600–3400 (m) (broad O–H stretching), 
3300 (m) (N–H stretching), 3099 (m) (aromatic C–H 
stretching asymmetric), 3056 (m) (aromatic C–H stretching 
symmetric), 2989 (m) (aliphatic C–H stretching asymmetric), 
2852 (m) (aliphatic C–H stretching symmetric), 1680 (s) 
(carbonyl stretching), 1620, 1552, 1447 (m) (skeleton in 
plane vibrations –C=C), 1408–1425 (s) (C=C and C=N 
ring stretching), 750 (N–H wagging), 741 (s) out of plane 
C=C bending, 1338 (s) SO2 stretching asymmetric, 1118 
(s) SO2 stretching symmetric, 565 (s) SO2 rocking, 532 (s) 
SO2 scissoring.
H1 NMR (DMSO-d6, 300 MHz), δ (ppm): 7.05–7.10 
(m, 4H, ArH), 3.70–3.80 (s, 1H, aromatic N–H, D2O 
exchangeable), 2.80 {d, 2H, –CH2 (Jvic = 7.2)}, 3.86 {t, 
1H, –CH (Jvic = 7.2)}, 11.00 (s, 1H, COOH), 7.95 (d, 2H, 
o-protons of ArH with respect to SO2 group), 7.30–7.50 (m, 
3H, ArH with respect to SO2), 4.55–4.60 (m, 2H, –CH2).
Mass spectra: Molecular ion peak M at m/e 356 (43.9%), 
[M–(OH)]+ at m/e 339 (18.8%). The other important ions 
are at m/e 330 (21.2%), 311 (13.5%), 216 (100%), 169 
(16.44%), 144 (20.54%), 141 (6.5%), 118 (22.4%), 117 
(23.7%), 91 (8.5%), 77 (9.4%), 51 (6.2%)
Procedure for the preparation of 2-(p-toluenesulfonyl)-
1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-
carboxylic acid (DM5)
Treated 3g (0.01389 M) of the amine (DM2) with 50 mL 
of 10% sodium hydroxide solution and 3 g (0.01574 M) of 
p-toluenesulfonyl chloride was added in small proportions. 
The reaction mixture was stirred vigorously for 30 min 
and warmed it slightly and shaking was continued. When 
the odor of p-toluenesulfonyl chloride was dissipated, the 
mixture was cooled in an ice bath. As oil started separating, 
crystallization was induced by rubbing the inner wall of the 
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beaker with the glass rod in an ice bath. Any solid produced 
should be separated by filtration, and the crude product 
was recrystallized from dilute ethanol to give pure DM5 as 
light brown crystals.
IR (KBr) cm–1: 3600–3400 (m) (broad O–H stretching), 
3300 (m) (N–H stretching), 3099 (m) (aromatic C–H 
stretching asymmetric), 3056 (m) (aromatic C–H stretching 
symmetric), 2989 (m) (aliphatic C–H stretching asymmetric), 
2852 (m) (aliphatic C–H stretching symmetric), 1680 (s) 
(carbonyl stretching), 1620, 1552, 1447 (m) (skeleton in 
plane vibrations C=C), 1408–1425 (s) (C=C and C=N ring 
stretching), 748 (m) (N–H wagging), 740 (s) out of plane 
C=C bending, 1328 (s) SO2 stretching asymmetric, 1122 
(s) SO2 stretching symmetric, 560 (s) SO2 rocking, 532 (s) 
SO2 scissoring.
1H-NMR (DMSO-d6, 300 MHz), δ (ppm): 7.05–7.10 
(m, 4H, ArH), 3.70–3.80 (s, 1H, aromatic N–H, D2O 
exchangeable), 2.80 {d, 2H, –CH2 (Jvic = 7.2)}, 3.88 {t, 
1H, –CH (Jvic = 7.2)}, 11.00 (s, 1H, COOH), 7.80 (d, 2H, 
o-protons of ArH with respect to SO2 group), 7.30–7.45 
(m, 2H, m-protons of ArH with respect to SO2 group), 
2.45 (s, 3H, –CH3), 4.55–4.62 (m, 2H, –CH2).
Mass spectra: Molecular ion peak M at m/e 370 (44.2%) 
and [M–(OH)]+ shows peak at m/e 353 (11.9%). The other 
important ions are at m/e 330 (21.4%), 325 (13.9%), 216 
(100%), 183 (6.44%), 155 (20.5%), 144 (14.2%), 118 (9.2%), 
117 (22.88%), 91 (8.5%), 91 (9.4%).
Evaluation of antidiabetic activity
The synthesized compounds were screened for in vivo 
antidiabetic activity in streptozotocin-induced diabetic 
rats. After administration of standard drug (pioglitazone) 
and synthesized compounds (DM1–5), serum glucose was 
estimated spectrophotometrically at 505 nm by glucose 
oxidase/peroxidase method using a commercially available 
kit (Span Diagnostic Ltd, Surat, India).
Concentration of glucose (mg/dL) = Optical density of 
test/Optical density of std. × 100.
The results are summarized in Table 2.
RESULTS AND DISCUSSION
The structures of synthesized compounds were confirmed 
by thin layer chromatography (TLC), m.p, IR, 1H-NMR, 
and mass spectrometry (MS) spectral analysis. The 
compounds (DM3–DM5) were synthesized by the treatment 
of l-tryptophan with formaldehyde which resulted in the 
formation of an intermediate α-hydroxymethylamino-β-
3-indolylpropionic acid (DM1) which after refluxing with 
ammonia solution for 3 h resulted in cyclized product 
DM2 (Scheme 1). The compound DM2 on further 
treatment with methanesulfonyl chloride, benzenesulfonyl 
chloride, and toluenesulfonyl chloride yields different 
1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylic 
acid derivatives (Scheme 2). The yield was found to be in 
range of 70–80%. The title compounds were confirmed by 
IR spectral data showing characteristic bands at 3650–3300 
cm–1 corresponding to OH stretching, sharp band at 1690 
cm–1 indicated the presence of C=O group. Compounds 
(DM3–DM5) were confirmed by stretching at 1330 and 1120 
cm–1 due to the presence of the SO2 group. Compounds 
DM1–DM5 was confirmed by 1H-NMR spectral analysis. 
The NMR proton singlet peak at δ 11 ppm and 3.70–3.80 
revealed the presence of carboxylic acid and aromatic N–H 
groups. Further appearance of molecular ion peak M at m/e 
294 (43.9%) 356 (43.9%), and 370 (44.2%) confirmed the 
structures of compounds (DM3–DM4). The compounds 
DM1 and DM2 do not significantly decrease blood glucose 
level in streptozotocin-induced diabetes. Compounds DM3 
and DM4 exhibited less activity, whereas compound DM5 
i.e., was found to possess better antidiabetic activity.
CONCLUSIONS
The yield of all 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-
3-carboxylic acid derivatives were found to be in the range 
70–80%. The purity of compounds was ascertained by 
meting point and TLC. The assigned structures were 
further established by IR,  1H-NMR, and mass spectral 
studies. The antidiabetic activity of the synthesized 
compounds was screened using streptozotocin-induced 
diabetes in rats. Pioglitazone was used as a standard drug. 
Compounds DM3 [2-(methylsulfonyl)-1,2,3,4-tetrahydro-
9H-pyrido[3,4-b]indole-3-carboxylic acid] and DM4 
[2-(phenylsulfonyl)-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]
Table 2: Antidiabetic activity of synthesized compounds 
against streptozotocin-induced diabetes in rats
Groups Blood glucose concentration (mg/dL)
DM1 176
DM2 179
DM3 154
DM4 167
DM5 145
Control 118
Streptozotocin treated 187
Pioglitazone treated 135136   Journal of Young Pharmacists Vol 3 / No 2
Scheme 1: Synthesis of DM2
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Scheme 2: Synthesis of DM3, DM4 and DM5
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indole-3-carboxylic acid] showed moderate activity, whereas 
compound DM5 [2-(p-toluenesulfonyl)-1,2,3,4-tetrahydro-
9H-pyrido[3,4-b]indole-3-carboxylic acid] exhibited the 
highest antidiabetic activity.
From this study, it may be concluded that the 
1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylic 
acid compounds can be potentially be developed into useful 
antidiabetic agents that can prompt future researchers to 
synthesize a series of 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]
indole-3-carboxylic acid derivatives containing a wide 
variety of substituents with the aim of obtaining novel 
compounds with enhanced activity.
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